Leadership

Officers

Dr. John Keller (President)
President & CEO
Shionogi Inc.

Dr. William Mann (Vice President)
President & CEO
Helsinn Therapeutics (U.S.) Inc.

Ms. Brianne Weingarten (Secretary)
Head of Alliance Management
Licensing & Business Development
Purdue Pharma

Mr. Shoji Yasuda (Treasurer)
President
Taisho Pharmaceutical R&D Inc.

Additional Members of
The Board of Directors

Mr. Yosuke Akita
Vice President, Corporate Planning
Eisai Inc.

Mr. John Bardi
Vice President, Government Affairs
Otsuka America Pharmaceuticals

Mr. Eric Benn
President & CEO
Taiho Oncology, Inc

Ms. Theresa Covert
AVP Business Development/Developed Markets
Global Human Health
Merck & Co., Inc.

Mr. Mark Dennish
Vice President, Business Development, New Product Planning & Oncology
Daiichi Sankyo Inc.

Dr. John Guarino
Head, Global Development Administration
Sunovion Pharmaceuticals Inc.

Dr. Thomas Heffner 
Executive Director, Global Business Development
Pfizer Inc.

Mr. Takeshi Masuda
President & CEO
Kyowa Kirin USA Holdings, Inc.

Dr. Blaine McKee
Head of Transactions
Shire

Mr. Takashi Nagao
President
Mitsubishi Tanabe Pharma Development America &
Mitsubishi Tanabe Pharma America

Mr. Kazumi Taguchi 
President
Kyorin USA Inc.

Ms. Jocelyn Trokenheim
Vice President, Corporate Development
Takeda Pharmaceuticals International, Inc.

Mr. Robert Ward
President & CEO
Radius Health

Mr. Tokuhisa Yamato
President
Kissei America, Inc.

Special Advisor

Mr. Hiroyuki Kawabata
Director, Health and Welfare Dept.
JETRO New York